Lipids & metabolic liver disease

Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001–2018

Cardiovasc DiabetolPublished Cohort study

Authors' conclusion

In conjunction with the results of the Boruta algorithm, METS-IR demonstrated a more significant association with all-cause and cardiovascular mortality in the U.S. population compared to the other three alternative IR indexes (TyG index, TG/HDL-C and HOMA-IR), particularly evident in individuals under 65 years old.

Study context

Population
General US population, NHANES 2001–2018
Participants
14,653 participants
Exposure
Four insulin resistance (IR) surrogate indexes for prediction of mortality
Outcome
All-cause and CVD mortality
Follow-up
Median 116 months
Methodological detailsNHANES 2001–2018, Boruta algorithm variable screening, multivariate Cox regression, restricted cubic splines
  • NHANES 2001–2018
  • Boruta algorithm variable screening
  • Multivariate Cox regression
  • Restricted cubic splines

Main finding

As reported in the abstract

All-cause deaths
2085 (10.23%)
Cardiovascular disease (CVD) deaths
549 (2.61%)
METS-IR below inflection point (41.33), all-cause mortality, HR
0.972 (0.950-0.997) (95% CI)
METS-IR above inflection point (41.33), all-cause mortality, HR
1.019 (1.011-1.026) (95% CI)
METS-IR above inflection point (41.33), CVD mortality, HR
1.028 (1.014-1.043) (95% CI)

Observational data: associations, not effects.

Further findings

METS-IR and mortality by age subgroup

Significant associations of METS-IR with all-cause and CVD mortality predominantly in nonelderly aged < 65 years

Original publication

Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001–2018. Cardiovasc Diabetol. Published 10 July 2024. doi:10.1186/s12933-024-02334-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.